Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patient must have been diagnosed with ovarian or primary peritoneal cancer
Patient must have had 1 or 2 prior platinum-based chemotherapeutic regimens.
Patient must have adequate health status.
Patient compliance and geographic proximity that allow for adequate follow up is required.
Signed informed consent from the patient or legal representative is required.
You may not be if
Patient is pregnant or breast-feeding
Patient has received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry.
Patient has previously participated in another study investigating pemetrexed.
Patient is unable or unwilling to take folic acid, vitamin B12 supplementation, and corticosteroids.
Patient cannot be taking nonsteroidal anti-inflammatory drugs around the time of administration of study drug.
